• About Us
  • Privacy Policy
No Result
View All Result
Express Day
  • Home
  • NEWS
    • Politics
    • Health
    • Education
    • Crime
    • Judiciary
    • Environment
    • Science & Technology
  • BUSINESS
    • Finance
    • Insurance
    • Agriculture
    • Aviation
    • Energy
    • ICT
    • Maritime & Transport
  • INVESTIGATIONS
  • ENTERTAINMENT & ARTS
  • SPORTS
Express Day
No Result
View All Result
Home NEWS Health

NAFDAC disowns Covid-19 drug produced by Catholic monks

ExpressDay by ExpressDay
May 1, 2020
in Health, NEWS, TOP STORIES
0
NAFDAC disowns Covid-19 drug produced by Catholic monks
0
SHARES
33
VIEWS
Share on FacebookShare on Twitter

The National Agency for Food and Drug Administration and Control (NAFDAC), has distanced itself from PAX CVD PLUS, a drug developed by Pax Herbal Clinic and Research Laboratories, owned by Catholic monks in Edo State, who claim it can treat Covid-19.

A statement signed by the agency’s Director General, Prof Mojisola Christianah Adeyeye, in Abuja, Friday evening, noted that the drug under contention- PAX CVD PLUS, had for not been registered by NAFDAC.

According to the statement: “The attention of the Agency has been drawn to an advertorial from Pax Herbal Clinic and Research Laboratories titled: “An Official Statement By Paxherbals on the Treatment Of COVID-19”.

“The advertorial claimed that Paxherbal has developed a new drug called PAX CVD PLUS for the treatment of COVID-19 and is working with NAFDAC to speed up approval for use of the drugs.

“The same advertorial claimed that the Director-General of NAFDAC has appointed experts to work with PAXHERBAL on what the company has described as a special project.

“NAFDAC wish to inform the public that PAX CVD PLUS has not been registered nor listed for treatment of COVD-19, neither have we registered nor listed any other remedy for COVID-19.

“To set the records straight, at no time did the Director-General of NAFDAC, Prof Mojisola Adeyeye, or anyone in the Agency appointed any expert or staff to work with PAXHERBAL on any project.

“The company wrote a letter to NAFDAC informing the Agency about their development of an antiviral plant based drug with potential to treat COVID-19 and an invitation to join their research team.

“The Agency politely declined since as a regulator of clinical trials, participation would be a conflict of interest.

“However, we encouraged them to carry out clinical trials which should be under strict supervision of the Agency to establish efficacy of their product. “However, the clinical trial has not taken place.

“It is therefore, unfortunate that PAXHERBALS have made claims that are not backed up by facts.” This response, the NAFDAC DG stressed, is intended to correct the erroneous impression created by the advertorial.”

Previous Post

Labour Day: Buhari salutes Nigerian workers through virtual meeting

Next Post

Covid-19: Union calls for uniform special allowance for health workers

ExpressDay

ExpressDay

Next Post
FG embarks on mandatory, supervised quarantine of persons returning from abroad

Covid-19: Union calls for uniform special allowance for health workers

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected test

  • Trending
  • Comments
  • Latest
Tinubu appoints new CEO for Refugees Commission

Tinubu appoints new CEO for Refugees Commission

September 15, 2023
Udochi Union celebrates Edo lawyer now Justice Commissioner in Kaduna 

Udochi Union celebrates Edo lawyer now Justice Commissioner in Kaduna 

September 25, 2023
Ofobrukueta lauds Gov Oborevwori for engaging Julius Berger to fix Delta roads

Ofobrukueta lauds Gov Oborevwori for engaging Julius Berger to fix Delta roads

September 22, 2023
Nollywood actress, Queeneth, spurns fan after sending friendship request

Nollywood actress, Queeneth, spurns fan after sending friendship request

October 18, 2022
Boost for 3m MSMEs as FG/ALAT launch Skillnovation 

Boost for 3m MSMEs as FG/ALAT launch Skillnovation 

September 29, 2023
Obaseki reconciles with estranged Deputy, Shaibu

Obaseki reconciles with estranged Deputy, Shaibu

September 29, 2023
Political Blackmailers and the Failed Attempts to Drown the Growing Calls for Uzodimma’s Re-election

Political Blackmailers and the Failed Attempts to Drown the Growing Calls for Uzodimma’s Re-election

September 29, 2023
Delta@32: Ethiope East LG boss, Ofobrukueta hails Oborevwori

PDP chieftains petition Gov Oborevwori over marginalization of Urhobos in Warri South

September 28, 2023

Recent News

Boost for 3m MSMEs as FG/ALAT launch Skillnovation 

Boost for 3m MSMEs as FG/ALAT launch Skillnovation 

September 29, 2023
Obaseki reconciles with estranged Deputy, Shaibu

Obaseki reconciles with estranged Deputy, Shaibu

September 29, 2023
Political Blackmailers and the Failed Attempts to Drown the Growing Calls for Uzodimma’s Re-election

Political Blackmailers and the Failed Attempts to Drown the Growing Calls for Uzodimma’s Re-election

September 29, 2023
Delta@32: Ethiope East LG boss, Ofobrukueta hails Oborevwori

PDP chieftains petition Gov Oborevwori over marginalization of Urhobos in Warri South

September 28, 2023

Follow Us

Browse by Category

  • Agriculture
  • Aviation
  • BUSINESS
  • Crime
  • Economy
  • Education
  • Energy
  • ENTERTAINMENT & ARTS
  • Environment
  • Feature
  • Finance
  • FOREIGN
  • Health
  • ICT
  • Insurance
  • INTERVIEW
  • INVESTIGATIONS
  • Judiciary
  • Maritime & Transport
  • Metro
  • NEWS
  • Oil and Gas
  • OPINION
  • PHOTO NEWS
  • Politics
  • Science & Technology
  • Security
  • SPORTS
  • TOP STORIES
  • Tourism

Recent News

Boost for 3m MSMEs as FG/ALAT launch Skillnovation 

Boost for 3m MSMEs as FG/ALAT launch Skillnovation 

September 29, 2023
Obaseki reconciles with estranged Deputy, Shaibu

Obaseki reconciles with estranged Deputy, Shaibu

September 29, 2023
  • About Us
  • Privacy Policy

© 2022 Express Day

No Result
View All Result
  • Home
  • NEWS
  • BUSINESS
  • INVESTIGATIONS
  • ENTERTAINMENT & ARTS
  • SPORTS

© 2022 Express Day